{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-082910","form_type":"8-K","ticker":"RLMD","cik":"0001553643","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.313917+00:00","generated_at":"2026-05-17T08:51:02.562447+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Relmada Therapeutics CMO-Urology buys 55,000 shares in open market on Aug 29, 2025","bullets":["Raj S. Pruthi, MD, Chief Medical Officer-Urology, purchased 55,000 shares of RLMD common stock on August 29, 2025.","The purchase was executed via open market transactions; no specific price disclosed in filing.","Insider purchase may signal management confidence in the company's outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-082910","json":"https://secwatch.observer/filing/0001213900-25-082910.json","markdown":"https://secwatch.observer/filing/0001213900-25-082910.md","text":"https://secwatch.observer/filing/0001213900-25-082910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025082910/0001213900-25-082910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025082910/ea0255475-8k_relmada.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:51:02.562447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}